Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacy Year 2 Semester 2 > COPD > Flashcards

COPD Flashcards

1
Q

Diagnosis

A 
no single diagnostic test 
Use combo of:
-history
-physical examination
-confirmation of airway obstruction using spirometry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define COPD

A

Airflow obstruction is defined as a reduced FEV1/FVC ratio (where FEV1 is forced expired volume in 1 second and FVC is forced vital capacity), such that FEV1/FVC is less than 0.7.

If FEV1 is ≥ 80% predicted normal a diagnosis of COPD should only be made in the presence of respiratory symptoms, for example breathlessness or cough.
The airflow obstruction is present because of a combination of airway and parenchymal damage. The damage is the result of chronic inflammation that differs from that seen in asthma and which is usually the result of tobacco smoke. Significant airflow obstruction may be present before the person is aware of it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Symptoms

A
  • exerational breathlessness
  • chronic cough
  • regular sputum production
  • frequent winter “bronchitis”
  • wheeze
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Compare airway obstruction in COPD to that of asthma

A

-permanently damaged and narrowed, therefore symptoms are persistent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Compare cough symptoms in COPD to that of asthma

A

-COPD: chronic cough with sputum

whereas in asthma- irritating cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Compare night time symptoms in COPD and asthma

A

COPD: Night time breathlessness and wheeze that keeps patients awake is NOT common, but it is in asthma and is variable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Compare age groups affected in COPD and asthma

A

COPD: More commonly over 35s
Asthma: more commonly under 35s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Compare likelihood of atopy (genetic) cause in COPD and asthma

A

COPD: Unlikely to be an atopy (genetic) cause
Asthma: Likely to be an atopy cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Compare likelihood of patients being smokers in COPD and Asthma

A

COPD: Nearly all patients are smokers
Asthma: Possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Patients that may be diagnosed with COPD should also be asked about what factors?

A
  • weight loss
  • effort intolerance
  • waking at night
  • ankle swelling
  • fatigue
  • occupational hazards
  • chest pain
  • haemoptysis (blood in mucous from couging)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What tests should patients receive to aid COPD diagnosis

A
  • spirometry
  • a chest radiograph to exclude other pathologies
  • FBC to identify anaemia or polycythaemia
  • BMI calculated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk factors for COPD

A
  • smoking
  • Age
  • male gender
  • alpha1 antitrypsin deficiency
  • occupation
  • existing impaired lung function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prognosis

A

COPD severity graded on FEV1%, breathlessness, symptoms etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the BODE index?

A

B- BMI
O- airflow obstruction
D- dysponea
E - exercise capacity

BODE used to assess prognosis
10 point score that assesses disease outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

COPD Staging

A

Mild: FEV1 >80% (or equal to)
Moderate: 50-79%
Severe: 30-49%
Very severe: <30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Number 1 in management is?

A

STOP SMOKING

Even with an FEV1<25%, smoking will increase life expectancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Treatment aims

A
  • stop smoking
  • improve symptoms
  • prevent acute infective exacerbations
  • reduce rate of disease progression
  • Maintain nutritional intake, BMI>20
  • Increase quality of light (QoL)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Outline the NICE inhaler treatment guideline for a COPD patient with an FEV>50% (or equal to)

A

-Breathlessness or exercise limitation - SAMA or SABA PRN
↓
-exacerbation or persistent breathlessness
-Add LAMA or LABA
↓
persistent exacerbations or breathlessness
-if LAMA for previous step→LABA+ICS combination inhaler. Consider LAMA and LABA if ICS is declined or not tolerated
-if LABA for previous step→LABA+ICS combination inhaler+LAMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Outline the NICE inhaler treatment guideline for a COPD patient with an FEV<50%

A

SAMA or SABA PRN
↓
exacerbations or persistent breathlessness
Either 1 or 2:
1) LABA+ICS combination inhaler and consider LAMA+LAMA if ICS is declined or not tolerated
2) LAMA (offer in preference to regular SAMA QDS.)
Discontinue SAMA
↓
persistent exacerbations or breathlessness
-LABA+ICS in combination inhaler + LAMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Benefit of LABA/SABA in spirometry terms

A

Modest increase in FEV1
Symptoms reduced
exercise capacity increases
health status improved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How do antimuscarinics work?

Name one LABA and one SAMA

A
  • they reduce vagal airway tone and reflex bronchoconstriction
  • SAMA - Ipratropium
  • LAMA - Tiotropium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

ADRs of antimuscarinics

A

Anticholinergic side effects:

  • dry mouth
  • blurred vision
  • urinary retention
  • constipation
  • hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

List drug classes for COPD treatment

A
  • B2-agonists - SABA, LABA
  • Anti-muscarinics - SAMA, LAMA
  • corticosteroids
  • Methylxanthines
  • Mucolytics
  • Roflumilast
24
Q

Important interactions with methylxanthines

A

Cigarette smoke

some antibioticcs

25
Q

Name some mucolytic drugs

A
  • Carbocisteine

- Mecysteine

26
Q

How do mucolytic drugs work

When are they used?

A
  • facilitate expectoration by reducing sputum viscosity
  • consider in patients with chronic productive cough
  • continue if improvement (stop after 4-week trial if no benefit)
27
Q

Roflumilast
What does it do?
Licensed for what?

A
  • Anti-inflammatory drug with similar actions to theophylline
  • only approved by NICE for CLINICAL TRIAL use only
28
Q

When is oxygen used for COPD patients?

A

improves hypoxia and reduces work of breathing
-used for acute exacerbations
and
-long term therapy if FEV<35% and is symptomatic
or
-if patient has polycythaemia or cor pulmonale
or
-if patient’s oxygen saturation is less than 92% on air or is chronically breathless to the point where it affects daily life

29
Q

LTOT is what?

Describe how it works

A

Long term oxygen therapy
>15 hours daily
-prolongs life
-Use 24-28% O2 (much lower than asthma, which is 40-60%)
-prevents reduction in respiratory drive
-O2 is a stimulus for for breathing due to chronic retention of CO2 - danger! High O2 concentrations - may cause respiratory depression

30
Q

NICE Criteria for LTOT

A

the assessment of patients for LTOT should comprise the measurement of arterial blood gases on two occasions at least 3 weeks apart in patients who have a confident diagnosis of COPD, who are receiving optimum medical management and whose COPD is stable.

Patients receiving LTOT should be reviewed at least once per year by practitioners familiar with LTOT and this review should include pulse oximetry. [2004]

31
Q

The need for oxygen therapy must be assessed in which COPD patients?

A

all patients with very severe airflow obstruction (FEV1 < 30% predicted)

patients with cyanosis

patients with polycythaemia

patients with peripheral oedema

patients with a raised jugular venous pressure

patients with oxygen saturations ≤ 92% breathing air.

Assessment should also be considered in patients with severe airflow obstruction (FEV1 30–49% predicted).

To ensure all patients eligible for LTOT are identified, pulse oximetry should be available in all healthcare settings

32
Q

Mainstay of COPD therapy

A

-SABA/LABA/LAMA and ICS if indicated
-mucolytics
-oxygen
-oral steroids (prednisolone)
-methylxanthines
are all additional add-on therapies if control is not stable or maintained

33
Q

is nebulised therapy ok to use at home?

Which COPD patients?

A

Nebulised therapy at home and spacer devices may be used in patients that remain breathless but are stable, having positive outcomes on day-to day activities i.e. daily tasks. Note home nebs are common in COPD but not asthma.

34
Q

Maintence oral steroids

A

Maintenance oral steroids are used at the lowest effective dose in patients that remain symptomatic – think ADRS, counselling and osteoporosis prophylaxis

35
Q

General one line assessment if need oxygen therapy

A

Assess need for oxygen (if FEV < 35% and breathless/hypoxic)

36
Q

General guidance to patients - non-pharmacological management

A
  • Stop smoking
  • encourage exercise
  • nutrition - BMI>20
  • flu and pneumococcal vaccine
37
Q

Compare treatment of acute exacerbations in COPD to that of asthma

A

Treat exacerbations very much like that of asthma:
-nebulised salbutamol and ipratropium
-consider theophylline
-oxygen use is different in COPD:
O2 saturation maintained at 88-92% in COPD
Note: Asthma 94-96%, hypercapnia

38
Q

Types of COPD acute exacerbations

A
  • infective

- non-infective

39
Q

Why are upper and lower respiratory tract infections common in COPD patients?

A
  • use of steroids

- lung degradation

40
Q

How are antibiotics chosen for COPD infections?

A
  • use local policy
  • lab sensitivity patterns
  • previous Rx (resistance)
41
Q

Common pathogens for lung infection in COPD patients and the treatment (1st choice and 2nd choice)

How long are the treatments?

A
  • Haemophilus influenzae
  • Streptococcus pneumoniae

1st choice - Amoxicillin 500mg TDS
or
Tetracycline (doxycycline 200mg stat and then 100mg OD)

2nd choice - broad spectrum macrolide or cephalosporin

Home: 7days
Hospital: 7-14 days

42
Q

What do you monitor a COPD patient has an acute exacerbation?

A 
•	Pulse oximetry/ABGs (arterial blood gases)
o	blood pH ~7.4 to prevent acidosis
o	O2 – 7 kPa
o	CO2 – hypercapnia
o	Detect cyanosis
o	Detect hypoxia
•	HR/RR (tachy-cardia/ponea)
•	CRP
•	WCC if infection suspected
•	theophylline levels (if continued >24h)
•	serum K+ (nebulised SABA)/glucose 
•	hydration
•	Blood pH ~ 7.4 (risk of acidosis)
•	C&amp;S – infection (RTI)
•	Sputum purulence
•	ECG and ECHO – cor pulmonale
•	JVP – cor pulmonale (jugular venous pressure)
•	RCC – polycythaemia
43
Q

When are antibiotics given?

A 
Given if 2 or more of increased 
-breathlessness
-sputum volume
-sputum purulence 
Give prednisolone 30mg for 7-10 days to reduce inflammation and give symptom relief
Increase bronchodilator - nebulised
44
Q

What is hypercapnia?

How does if affect treatment?

A
  • COPD patients will have a change in respiratory drive
  • a COPD patient is used to high CO2 levels so adopt to take a breath when oxygen is low (instead of what happens in healthy individuals- they take a breath when CO2 levels are high)
  • this is hypercapnia
  • many COPD patients are chronically hypoxic
  • this hypoxia affects oxygen administration in patients, - a high O2 concentration removes patient’s drive to take a breath (when O2 is low)
  • Therefore O2 can be fatal to COPD patients
45
Q

Hypoxia drives what 3 complications of COPD?

A

-hypercapnia
-cor pulmonale
-polycythaemia
This affects cardiac function

46
Q

When can hypercapnia be extremely fatal?

A

If oxygen is administered and is not adjusted to hypercapnic patient

47
Q

Long term corticosteroid use can lead to what?

Is there any kind of treatment for this?

A
  • leads to osteoporosis

- offer patient prophylactic treatments

48
Q

What is Cor pulmonale?

A
  • Right heart failure - 90% due to COPD
  • due to pulmonary hypertension and thus blood flow resistance in the damaged vasculature
  • hypoxia (secondary to hypercapnia)
  • requiring an increased oxygen demand and polycythaemia
49
Q

Symptoms of Cor pulmonale

A
  • peripheral oedema
  • hepatomegaly
  • raised JVP (jugular venous pressure)
50
Q

Rx for cor pulmonale

A
  • diuretics to reduce oedema

- O2 to reduce hypoxia

51
Q

What is polycythaemia?

A

Increased number of RBCs in response to chronic hypoxia

↓O2→↑RBC→↑haematocrit→↑blood viscosity

52
Q

Treatment for polycythaemia

A
  • prescribe O2 to reduce hypoxia

- Venesection - remove blood

53
Q

Review time for COPD patients

A

minimum annually
Care under wider MDT-
doctor, nurse, physio, dietician, pharmacy, social work, occupational therapists etc.

54
Q

BMI for COPD patients

A

BMI must be maintained between 20-25 (weight kg/height meter2); a low BMI has demonstrated a higher mortality.

55
Q

what is pulmonary rehabilitation?

when is it offered?

A
  • offered to all patients who consider themselves functionally disabled by COPD
  • Incorporates a programme of physical training (physiotherapy), disease education, nutritional (maintain BMI>20), psychological and behavioural intervention
56
Q

All COPD must recieve…

A

All patients must receive annual vaccinations:
• Influenza
• Pneumococcal
Along with annual FEV1, dyspnoea score, BODE index, BMI

57
Q

Outline self-care in COPD

A

Patients should be encouraged to respond promptly to the symptoms of exacerbation at home by:

  • starting their oral corticosteroid therapy if their increased breathlessness interferes with activities of daily living
  • starting antibiotic therapy if their sputum is purulent
  • adjusting their bronchodilator therapy to control their symptoms

Patients at risk of having exacerbation of COPD should be given a course of antibiotic and corticosteroid tablets to keep at home for use as a “self-management” strategy or “rescue-therapy”
Patients given self-management should be advised to contact a healthcare professional if they do not improve

Pharmacy Year 2 Semester 2 (33 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions